Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

N. Hatam; N. Ahmadloo; A. Ahmad Kia Daliri; P. Bastani; M. Askarian

首页> 外文期刊>Archives of Gynecology and Obstetrics >Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

【24h】

Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

机译：与FAC（阿霉素，环磷酰胺，5-氟尿嘧啶）相比，使用辅助TAC（多西他赛，阿霉素，环磷酰胺）的乳腺癌患者的生活质量和毒性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Objectives The aim of this study was to compare two regimens of chemotherapy in patients with breast cancer, including FAC (doxorubicin, cyclophosphamide, and 5-fluorouracil) and TAC (docetaxel, doxorubicin and cyclophosphamide); and analyze the toxicity of these treatments and observe patient’s health-related quality of life.

机译：目的本研究的目的是比较两种乳腺癌患者的化疗方案，包括FAC（阿霉素，环磷酰胺和5-氟尿嘧啶）和TAC（多西他赛，阿霉素和环磷酰胺）。并分析这些疗法的毒性，并观察患者健康相关的生活质量。

著录项

来源
《Archives of Gynecology and Obstetrics》 |2011年第1期|p.215-220|共6页
作者
N. Hatam; N. Ahmadloo; A. Ahmad Kia Daliri; P. Bastani; M. Askarian;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil). [J] . Hatam N, Ahmadloo N, Ahmad Kia Daliri A, Archives of gynecology and obstetrics. . 2011,第1期

机译：与FAC（阿霉素，环磷酰胺，5-氟尿嘧啶）相比，使用辅助TAC（多西他赛，阿霉素，环磷酰胺）的乳腺癌患者的生活质量和毒性。
2. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen [J] . M. Martín, A. Lluch, M. A. Seguí, Annals of Oncology . 2006,第8期

机译：接受多西他赛，阿霉素，环磷酰胺（TAC）或5-氟尿嘧啶，阿霉素和环磷酰胺（FAC）辅助治疗的乳腺癌患者的毒性和健康相关的生活质量：在TAC方案中添加主要预防性粒细胞集落刺激因子的影响
3. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colon [J] . Martin M, Lluch A, Segui MA, Annals of oncology: official journal of the European Society for Medical Oncology . 2006,第8期

机译：接受多西他赛，阿霉素，环磷酰胺（TAC）或5-氟尿嘧啶，阿霉素和环磷酰胺（FAC）辅助治疗的乳腺癌患者的毒性和健康相关的生活质量：添加初级预防性粒细胞结肠的影响
4. Use of Laser Photomodulation in the Evolution of Oral Mucositis Associated to Cyclophosphamide, Methotrexate, 5-Fluouracil - CMF in 5 Fluouracil + Adriamycin + Cyclophosphamide - FAC Chemotherapy Protocols in Patients with Breast Cancer [C] . Maria de Fatima Lima Ferreira, Fabiola Bastos de Carvalho, Susana C. P. S. de Oliveira, Mechanisms for low-light therapy VIII . 2013

机译：激光光调节在5种氟尿嘧啶+阿霉素+环磷酰胺-FAC化疗方案中与环磷酰胺，甲氨蝶呤，5-氟尿嘧啶-CMF相关的口腔黏膜演变中的应用
5. Humanin significantly reduces cyclophosphamide and doxorubicin induced germ cell apoptosis in-vivo and ex-vivo mice [D] . Ohanyan, Aikoui 2013

机译：Humanin显着降低环磷酰胺和阿霉素诱导的体内和体外小鼠生殖细胞凋亡
6. Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide followed by adjuvant capecitabine/docetaxel vs docetaxel in patients with operable breast cancer [O] . Minmin Zhang, Wei Wei, Jianlun Liu, 2016

机译：在可手术乳腺癌患者中新辅助化疗方案卡培他滨/厄比霉素/环磷酰胺与5-氟尿嘧啶/厄比霉素/环磷酰胺再辅以卡培他滨/多西他赛与多西他赛的疗效和毒性比较
7. PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WITH DOCETAXEL FOR EARLY BREAST CANCER: COST-EFFECTIVENESS ANALYSIS (CEA) OF A DOCETAXEL, DOXORUBICIN AND CYCLOPHOSPHAMIDE REGIMEN (TAC) VERSUS 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE (FAC) IN FRANCE [O] . Miadi-Fargier H, Le Pen C, Woronoff-Lemsi MC, 2005

机译：PCN12辅助化疗与DOCETAXEL对早期乳腺癌的影响：DOCETAXEL，阿霉素和环磷酰胺（TAC）与5-氟尿嘧啶，阿霉素，环磷酰胺和环磷酰胺的成本效益分析（CEA）
8. Enhancement of an Allogeneic GM-CSF-Secreting Breast Cancer Vaccine by Immunomodulatory Doses of Cyclophosphamide and Doxorubicin [R] . Emens, L. A. , Jaffee, E. M. 2003

机译：通过环磷酰胺和阿霉素的免疫调节剂量增强同种异体Gm-CsF分泌乳腺癌疫苗

Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅